Evidence map›Paper›PMID 41405177›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2025

Counting the Cost: The Hidden Financial Realities of Neuromuscular Disease Through Patient and Family Perspectives.

Homira Osman, Zainab Adamji, Stacey Lintern, Ian C Smith, Alyssa Grant, Lola E R Lessard, Hanns Lochmuller, Hugh McMillan, Kathryn Selby, Gerald Pfeffer and 4 more

Abstract read
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Counting the Cost: The Hidden Financial Realities of Neuromuscular Disease Through Patient and Family Perspectives.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Homira OsmanMuscular Dystrophy Canada, Toronto, Ontario, Canada.ORCID 0009-0001-7294-5105
Zainab AdamjiMuscular Dystrophy Canada, Toronto, Ontario, Canada.ORCID 0009-0002-9728-3790
Stacey LinternMuscular Dystrophy Canada, Toronto, Ontario, Canada.
Ian C SmithThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0001-5269-1710
Alyssa GrantThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0003-3374-5212
Lola E R LessardFaculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0002-3141-0227
Hanns LochmullerThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0003-2324-8001
Hugh McMillanFaculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0001-8927-2018
Kathryn SelbyBritish Columbia Children's Hospital, Vancouver, British Columbia, Canada.ORCID 0000-0001-9239-1704
Gerald PfefferDepartment of Clinical Neurosciences, Hotchkiss Brain Institute, Calgary, Alberta, Canada.ORCID 0000-0002-7657-7098
Lawrence KorngutDepartment of Clinical Neurosciences, Hotchkiss Brain Institute, Calgary, Alberta, Canada.ORCID 0000-0003-1594-5923
Cynthia GagnonUniversity of Sherbrooke, Sherbrooke, Quebec, Canada.ORCID 0000-0003-2829-8470
Kednapa ThavornThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0003-4738-8447
Jodi Warman-ChardonThe Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-0187-2199

Funding

AFM-Téléthon Grant #28653Canada Foundation for Innovation CFI-JELF 38412Canada Research Chair in Neuromuscular Genomics and Health 950-232279Canada Research ChairsCanada Research Coordinating Committee New Frontiers in Research Fund NFRFG-2022-00033Canadian Institutes of Health Research (CIHR) for Foundation Grant FDN-167281 (Precision Health for Neuromuscular Diseases)Canadian Institutes of Health Research (CIHR) for Foundation Grant Network Grant OR2-189333 (NMD4C)Canadian Institutes of Health Research (CIHR) for Foundation Grant Transnational Team Grant ERT-174211 (ProDGNE)CIHR #178534CIHR INS-464765Department of Medicine University of Ottawa Clinical Research ChairEric Poulin ALS Translational Research FundEuropean Commission Grant #101080249Government of Canada First Research Excellence Fund (CFREF) for the Brain-Heart Interconnectome CFREF-2022-00007Muscular Dystrophy Canada 932196Physician Services Incorporated 19-28
6 · The paper itself

Abstract

introductionNeuromuscular diseases (NMDs) impose multifaceted challenges on individuals and their families, often resulting in significant medical and non-medical expenses. While cost-of-illness (COI) studies provide valuable quantitative data, few explore the lived experience of financial strain. This study aims to identify the complex, often hidden, financial impacts experienced by individuals with NMDs and their families.

methodsWe conducted a qualitative study involving four virtual semi-structured focus groups, with 58 participants (76% patients and 24% caregivers). Participants were recruited from Muscular Dystrophy Canada's database and had previously completed the national BIND COI survey. Participants shared firsthand accounts of direct non-medical costs, psychosocial burdens and opportunity costs, highlighting hidden expenses, substantial out-of-pocket costs, and the broader financial and emotional toll on families. Thematic analysis of the transcripts of the discussions was performed using an inductive approach, guided by a rare-disease-specific socio-economic burden framework.

resultsFour key themes emerged: informational costs (lack of awareness/support for navigating financial resources), time-related costs (time spent advocating for supports), opportunity costs (loss of income or career advancement), and costs to independence (emotional toll and out-of-pocket costs for assistive devices and home modifications).

conclusionThis study identified four interconnected categories of hidden costs for people with NMDs and their families: informational burdens, administrative and advocacy demands, employment-related opportunity costs, and reduced independence tied to out-of-pocket spending on equipment and home modifications. These findings reveal how financial and emotional pressures accumulate beyond what traditional COI estimates capture. Greater attention to these costs is critical for fostering equitable and sustainable healthcare systems. PATIENT OR PUBLIC CONTRIBUTION: This study was designed and conducted in partnership with individuals living with NMDs and caregivers. Three trained patient and family research partners contributed to the development of the focus group guide and interpretation of results. All participants contributed their lived experiences to inform and validate key findings. Their input was central to the design, analysis and preparation of this manuscript, ensuring alignment with community priorities.

Indexed as

Cost of IllnessFinancial StressNeuromuscular DiseasesAdultCanadaFocus GroupsFunctional StatusHumansMiddle AgedQualitative ResearchSocial SupportYoung Adultfinancial impactneuromuscular diseasepatient lived experiencequality of liferare diseasesocio‐economic burden

Identifiers

PMID41405177
PMCPMC12710084

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.